Dr. Rita Kalyani, MD

Claim this profile

Johns Hopkins School of Medicine

Studies Kidney Disease
Studies Diabetic Kidney Disease
1 reported clinical trial
3 drugs studied

Affiliated Hospitals

Image of trial facility.
Johns Hopkins School Of Medicine

Clinical Trials Rita Kalyani, MD is currently running

Image of trial facility.

Combo Diabetes Drug

for Type 2 Diabetes

PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative treatments for patients with type 2 diabetes (T2D) and either established atherosclerotic cardiovascular disease (ASCVD) or at high risk for ASCVD. To accomplish this objective, we will randomly assign 6,000 patients with established T2D and ASCVD or high-risk for ASCVD in a 1:1 allocation to sodium-glucose cotransporter-2 inhibitor (SGLT2i) or glucagon-like peptide-1 receptor agonists (GLP-1RA). Participants will be followed for the occurrence of the trial primary endpoint of the total (first and recurrent) number of episodes of myocardial infarction (MI), stroke, arterial revascularization, hospitalization for heart failure, development of end-stage kidney disease, kidney transplantation, and mortality, counting all events from randomization until end of study.
Recruiting3 awards Phase 48 criteria

More about Rita Kalyani, MD

Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Rita Kalyani, MD has experience with
  • Combination Drug
  • GLP-1 Receptor Agonist
  • SGLT2 Inhibitor
Breakdown of trials Rita Kalyani, MD has run
Kidney Disease
Diabetic Kidney Disease
Diabetes Mellitus
Hypertension
Diabetes

Other Doctors you might be interested in

Jodi Segal, MDJohns Hopkins School of Medicine
Ning Cao, MDMoss Rehabilitation Research Institute
Julie Hoover-Fong, MDJohns Hopkins School of Medicine

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rita Kalyani, MD specialize in?
Rita Kalyani, MD focuses on Kidney Disease and Diabetic Kidney Disease. In particular, much of their work with Kidney Disease has involved treating patients, or patients who are undergoing treatment.
Is Rita Kalyani, MD currently recruiting for clinical trials?
Yes, Rita Kalyani, MD is currently recruiting for 1 clinical trial in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Rita Kalyani, MD has studied deeply?
Yes, Rita Kalyani, MD has studied treatments such as Combination drug, GLP-1 receptor agonist, SGLT2 inhibitor.
What is the best way to schedule an appointment with Rita Kalyani, MD?
Apply for one of the trials that Rita Kalyani, MD is conducting.
What is the office address of Rita Kalyani, MD?
The office of Rita Kalyani, MD is located at: Johns Hopkins School of Medicine, Baltimore, Maryland 21205 United States. This is the address for their practice at the Johns Hopkins School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top